http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013515581-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0681 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2016-0027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0625 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0098 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-001 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M16-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-00 |
| filingDate | 2010-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013515581-A |
| titleOfInvention | Device for oral administration of aerosol to the nasopharynx, nasal cavity, or sinuses |
| abstract | Deliver particles with a particle generator between 10nm and 200μm in size, mouthpiece or mouth mask for oral administration of aerosol during the nasal expiration phase or during the respiratory arrest phase prior to nasal expiration A device for administering an aerosol consisting of a gas source or a pressure source, the mouthpiece being airtight and extending beyond the patient's teeth by a length of up to 4 cm A means for administering aerosol to the nasal cavity, nasopharynx, or sinuses during which the aerosol can be applied sequentially to the mouth, to the nasopharynx, and then to the nasal cavity and sinuses Enabled, then allowing the aerosol to escape from one or both of the patient's nostrils, and the device disables oral exhalation during the aerosol administration phase and aerosol particles are delivered to the lungs. It is characterized by not. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11278684-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019513436-A |
| priorityDate | 2009-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.